

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.01265328 |
| 2 | locomotory exploration behavior (GO:0035641) | 4.78118374 |
| 3 | synaptic vesicle maturation (GO:0016188) | 4.77196581 |
| 4 | cellular potassium ion homeostasis (GO:0030007) | 4.35021089 |
| 5 | glutamate secretion (GO:0014047) | 4.29473210 |
| 6 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.08523905 |
| 7 | synaptic vesicle exocytosis (GO:0016079) | 4.07933715 |
| 8 | cholesterol efflux (GO:0033344) | 4.06158849 |
| 9 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.06007739 |
| 10 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.03570252 |
| 11 | vocalization behavior (GO:0071625) | 4.02778828 |
| 12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.97511466 |
| 13 | negative regulation of fibrinolysis (GO:0051918) | 3.95115473 |
| 14 | regulation of protein activation cascade (GO:2000257) | 3.81381024 |
| 15 | complement activation, alternative pathway (GO:0006957) | 3.81100122 |
| 16 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.79371604 |
| 17 | regulation of apoptotic cell clearance (GO:2000425) | 3.78943631 |
| 18 | regulation of complement activation (GO:0030449) | 3.77954077 |
| 19 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.65930755 |
| 20 | plasma lipoprotein particle assembly (GO:0034377) | 3.64664467 |
| 21 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.60779519 |
| 22 | gamma-aminobutyric acid transport (GO:0015812) | 3.60372807 |
| 23 | sodium ion export (GO:0071436) | 3.58726223 |
| 24 | proline transport (GO:0015824) | 3.56650745 |
| 25 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.55610072 |
| 26 | regulation of cholesterol esterification (GO:0010872) | 3.54991036 |
| 27 | low-density lipoprotein particle remodeling (GO:0034374) | 3.54725931 |
| 28 | regulation of synaptic vesicle transport (GO:1902803) | 3.51855803 |
| 29 | protein-lipid complex assembly (GO:0065005) | 3.49497172 |
| 30 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.47621416 |
| 31 | glucocorticoid metabolic process (GO:0008211) | 3.46805996 |
| 32 | regulation of fibrinolysis (GO:0051917) | 3.45833224 |
| 33 | neurotransmitter secretion (GO:0007269) | 3.44956246 |
| 34 | regulation of cholesterol homeostasis (GO:2000188) | 3.41879910 |
| 35 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.39105929 |
| 36 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.38427648 |
| 37 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.36494183 |
| 38 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.36450392 |
| 39 | layer formation in cerebral cortex (GO:0021819) | 3.33421535 |
| 40 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.32563112 |
| 41 | protein-lipid complex remodeling (GO:0034368) | 3.31871293 |
| 42 | macromolecular complex remodeling (GO:0034367) | 3.31871293 |
| 43 | plasma lipoprotein particle remodeling (GO:0034369) | 3.31871293 |
| 44 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 3.30990497 |
| 45 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.28856416 |
| 46 | neuronal action potential propagation (GO:0019227) | 3.27390912 |
| 47 | L-amino acid import (GO:0043092) | 3.22654039 |
| 48 | exploration behavior (GO:0035640) | 3.22301280 |
| 49 | reverse cholesterol transport (GO:0043691) | 3.21388130 |
| 50 | synaptic transmission, glutamatergic (GO:0035249) | 3.15280339 |
| 51 | glutamate receptor signaling pathway (GO:0007215) | 3.13198636 |
| 52 | high-density lipoprotein particle remodeling (GO:0034375) | 3.12941513 |
| 53 | plasma lipoprotein particle organization (GO:0071827) | 3.11869449 |
| 54 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.10896641 |
| 55 | protein carboxylation (GO:0018214) | 3.10896641 |
| 56 | progesterone metabolic process (GO:0042448) | 3.08331583 |
| 57 | plasma lipoprotein particle clearance (GO:0034381) | 3.07777433 |
| 58 | response to follicle-stimulating hormone (GO:0032354) | 3.07309105 |
| 59 | protein-lipid complex subunit organization (GO:0071825) | 3.06796077 |
| 60 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.05898865 |
| 61 | phospholipid efflux (GO:0033700) | 3.05774168 |
| 62 | synaptic vesicle endocytosis (GO:0048488) | 3.03787838 |
| 63 | negative regulation of sterol transport (GO:0032372) | 3.03142820 |
| 64 | negative regulation of cholesterol transport (GO:0032375) | 3.03142820 |
| 65 | glucocorticoid biosynthetic process (GO:0006704) | 3.02612960 |
| 66 | protein localization to synapse (GO:0035418) | 3.01701010 |
| 67 | long-term memory (GO:0007616) | 3.01672130 |
| 68 | regulation of synapse structural plasticity (GO:0051823) | 3.01349724 |
| 69 | C21-steroid hormone metabolic process (GO:0008207) | 2.99910288 |
| 70 | low-density lipoprotein particle clearance (GO:0034383) | 2.98394453 |
| 71 | positive regulation of steroid metabolic process (GO:0045940) | 2.96691960 |
| 72 | long-term synaptic potentiation (GO:0060291) | 2.93878655 |
| 73 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.93765911 |
| 74 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.93743479 |
| 75 | neuron-neuron synaptic transmission (GO:0007270) | 2.92044774 |
| 76 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.90630588 |
| 77 | neuron cell-cell adhesion (GO:0007158) | 2.88802856 |
| 78 | regulation of cholesterol storage (GO:0010885) | 2.86212156 |
| 79 | positive regulation by symbiont of host defense response (GO:0052509) | 2.84024152 |
| 80 | modulation by symbiont of host defense response (GO:0052031) | 2.84024152 |
| 81 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.84024152 |
| 82 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.84024152 |
| 83 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.84024152 |
| 84 | modulation by symbiont of host immune response (GO:0052553) | 2.84024152 |
| 85 | potassium ion import (GO:0010107) | 2.83908986 |
| 86 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.83696811 |
| 87 | regulation of ARF protein signal transduction (GO:0032012) | 2.81369737 |
| 88 | response to methylmercury (GO:0051597) | 2.80474154 |
| 89 | vesicle transport along microtubule (GO:0047496) | 2.79641572 |
| 90 | neuromuscular process controlling balance (GO:0050885) | 2.78642998 |
| 91 | regulation of synaptic plasticity (GO:0048167) | 2.78579872 |
| 92 | alanine transport (GO:0032328) | 2.76606473 |
| 93 | amino acid import (GO:0043090) | 2.74108454 |
| 94 | response to auditory stimulus (GO:0010996) | 2.73004370 |
| 95 | positive regulation of extracellular matrix organization (GO:1903055) | 2.72426520 |
| 96 | neurotransmitter transport (GO:0006836) | 2.71710949 |
| 97 | positive regulation of synapse maturation (GO:0090129) | 2.70396819 |
| 98 | regulation of postsynaptic membrane potential (GO:0060078) | 2.70255875 |
| 99 | nerve growth factor signaling pathway (GO:0038180) | 2.70022055 |
| 100 | macrophage activation involved in immune response (GO:0002281) | 2.68915060 |
| 101 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.67736283 |
| 102 | glutamate metabolic process (GO:0006536) | 2.67653844 |
| 103 | response to histamine (GO:0034776) | 2.67356175 |
| 104 | intestinal cholesterol absorption (GO:0030299) | 2.66991781 |
| 105 | activation of protein kinase A activity (GO:0034199) | 2.66734864 |
| 106 | androgen biosynthetic process (GO:0006702) | 2.66672494 |
| 107 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.65071305 |
| 108 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.63753678 |
| 109 | detection of molecule of bacterial origin (GO:0032490) | 2.63309118 |
| 110 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.62042615 |
| 111 | sterol transport (GO:0015918) | 2.61354944 |
| 112 | cholesterol transport (GO:0030301) | 2.61354944 |
| 113 | regulation of beta-amyloid formation (GO:1902003) | 2.60389033 |
| 114 | chondroitin sulfate catabolic process (GO:0030207) | 2.59579812 |
| 115 | neuromuscular process controlling posture (GO:0050884) | 2.58343566 |
| 116 | positive regulation of steroid biosynthetic process (GO:0010893) | 2.58234206 |
| 117 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.57651149 |
| 118 | dendrite morphogenesis (GO:0048813) | 2.57380015 |
| 119 | cellular sodium ion homeostasis (GO:0006883) | 2.56262077 |
| 120 | mating behavior (GO:0007617) | 2.55908279 |
| 121 | neuronal ion channel clustering (GO:0045161) | 2.55361514 |
| 122 | protein localization to endosome (GO:0036010) | 2.54602870 |
| 123 | regulation of neurotransmitter secretion (GO:0046928) | 2.54544092 |
| 124 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.54087588 |
| 125 | C21-steroid hormone biosynthetic process (GO:0006700) | 2.53008609 |
| 126 | potassium ion homeostasis (GO:0055075) | 2.52584140 |
| 127 | regulation of neurotransmitter levels (GO:0001505) | 2.51191342 |
| 128 | transmission of nerve impulse (GO:0019226) | 2.50082275 |
| 129 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 2.48510015 |
| 130 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.47786791 |
| 131 | L-phenylalanine catabolic process (GO:0006559) | 2.46541931 |
| 132 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.46541931 |
| 133 | cerebellar granule cell differentiation (GO:0021707) | 2.46533841 |
| 134 | oligosaccharide catabolic process (GO:0009313) | 2.46210742 |
| 135 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.44504907 |
| 136 | positive regulation of phagocytosis (GO:0050766) | 2.43787670 |
| 137 | negative regulation of lipid transport (GO:0032369) | 2.42822018 |
| 138 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.42466735 |
| 139 | cell communication by electrical coupling (GO:0010644) | 2.42233210 |
| 140 | membrane depolarization during action potential (GO:0086010) | 2.41326922 |
| 141 | positive regulation of membrane potential (GO:0045838) | 2.40428543 |
| 142 | glycosphingolipid catabolic process (GO:0046479) | 2.38329083 |
| 143 | negative regulation of amino acid transport (GO:0051956) | 2.37167012 |
| 144 | regulation of cellular amide metabolic process (GO:0034248) | 2.36880018 |
| 145 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.36801513 |
| 146 | blood coagulation, intrinsic pathway (GO:0007597) | 2.36263041 |
| 147 | clathrin coat assembly (GO:0048268) | 2.36150668 |
| 148 | negative regulation of cell killing (GO:0031342) | 2.36120467 |
| 149 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.36120467 |
| 150 | axonal fasciculation (GO:0007413) | 2.35680844 |
| 151 | regulation of macrophage chemotaxis (GO:0010758) | 2.35403058 |
| 152 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.35273781 |
| 153 | axon ensheathment in central nervous system (GO:0032291) | 2.34282440 |
| 154 | central nervous system myelination (GO:0022010) | 2.34282440 |
| 155 | positive regulation of synaptic transmission (GO:0050806) | 2.34039799 |
| 156 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.33615329 |
| 157 | regulation of cholesterol metabolic process (GO:0090181) | 2.33199189 |
| 158 | glycine transport (GO:0015816) | 2.33041431 |
| 159 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.32424673 |
| 160 | L-phenylalanine metabolic process (GO:0006558) | 2.32424673 |
| 161 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.32091367 |
| 162 | regulation of neurotransmitter transport (GO:0051588) | 2.31854475 |
| 163 | membrane depolarization (GO:0051899) | 2.31760746 |
| 164 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.30869302 |
| 165 | negative regulation of protein activation cascade (GO:2000258) | 2.30118078 |
| 166 | positive regulation of Rap GTPase activity (GO:0032854) | 2.30096627 |
| 167 | innervation (GO:0060384) | 2.29575973 |
| 168 | complement activation, classical pathway (GO:0006958) | 2.28082748 |
| 169 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.27588826 |
| 170 | neuromuscular process (GO:0050905) | 2.27478885 |
| 171 | regulation of vesicle fusion (GO:0031338) | 2.26855229 |
| 172 | neuron recognition (GO:0008038) | 2.26407192 |
| 173 | long term synaptic depression (GO:0060292) | 2.24672752 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.39681995 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.13421876 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.57487765 |
| 4 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.39322948 |
| 5 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.30762734 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.26818933 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.26737646 |
| 8 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.23645705 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.07273517 |
| 10 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.06037104 |
| 11 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.04808628 |
| 12 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.01896153 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.98066100 |
| 14 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.97636607 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.96765501 |
| 16 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.96245165 |
| 17 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.95851576 |
| 18 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.95851576 |
| 19 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.89889712 |
| 20 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.88805456 |
| 21 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.87051707 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.84821119 |
| 23 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.81692291 |
| 24 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.73806723 |
| 25 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.72326171 |
| 26 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.66982186 |
| 27 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.66781864 |
| 28 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.63086298 |
| 29 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.60873381 |
| 30 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.58194914 |
| 31 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.58181403 |
| 32 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.53055399 |
| 33 | TP53_16413492_ChIP-PET_HCT116_Human | 1.51160411 |
| 34 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.50290675 |
| 35 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.50093432 |
| 36 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.49349197 |
| 37 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.47691826 |
| 38 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.45240586 |
| 39 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.44446702 |
| 40 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.43826222 |
| 41 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.43165190 |
| 42 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.39987425 |
| 43 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.39295413 |
| 44 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.38738256 |
| 45 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.38513210 |
| 46 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.37143475 |
| 47 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.35513479 |
| 48 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.34304587 |
| 49 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.34230475 |
| 50 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.30717348 |
| 51 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.29387355 |
| 52 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.26538822 |
| 53 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.25948519 |
| 54 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.24608307 |
| 55 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.24440985 |
| 56 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.23602574 |
| 57 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.23221357 |
| 58 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.22963179 |
| 59 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.22913496 |
| 60 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.22222988 |
| 61 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.22044867 |
| 62 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.21937582 |
| 63 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.21548347 |
| 64 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.21296397 |
| 65 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.20457706 |
| 66 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.20135124 |
| 67 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.19233337 |
| 68 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.18736286 |
| 69 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.18379584 |
| 70 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.18211812 |
| 71 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.17676480 |
| 72 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.17631682 |
| 73 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.15525889 |
| 74 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.15424631 |
| 75 | RXR_22108803_ChIP-Seq_LS180_Human | 1.15355190 |
| 76 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.14874856 |
| 77 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14522078 |
| 78 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.13958536 |
| 79 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.13075748 |
| 80 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.12787230 |
| 81 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.12683270 |
| 82 | AR_25329375_ChIP-Seq_VCAP_Human | 1.12511161 |
| 83 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.12373170 |
| 84 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.12364509 |
| 85 | STAT3_23295773_ChIP-Seq_U87_Human | 1.11928040 |
| 86 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.11657949 |
| 87 | * MITF_21258399_ChIP-Seq_MELANOMA_Human | 1.11193772 |
| 88 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.10117418 |
| 89 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09876469 |
| 90 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.09532999 |
| 91 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.08915929 |
| 92 | * AR_19668381_ChIP-Seq_PC3_Human | 1.08593966 |
| 93 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.08257981 |
| 94 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.08257981 |
| 95 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.07814844 |
| 96 | P300_19829295_ChIP-Seq_ESCs_Human | 1.05889165 |
| 97 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.05446552 |
| 98 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.04128554 |
| 99 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.03492082 |
| 100 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.03225026 |
| 101 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.02796981 |
| 102 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.02712758 |
| 103 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.01920261 |
| 104 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.01624777 |
| 105 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.00434576 |
| 106 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.00186544 |
| 107 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.00117759 |
| 108 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.99881685 |
| 109 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99669682 |
| 110 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.98685390 |
| 111 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.98433154 |
| 112 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.98100070 |
| 113 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.97911338 |
| 114 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.97652959 |
| 115 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.97445537 |
| 116 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.96677083 |
| 117 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.96677083 |
| 118 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.96654784 |
| 119 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.96537192 |
| 120 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.95686172 |
| 121 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.95461671 |
| 122 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95214668 |
| 123 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.94469896 |
| 124 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.93744875 |
| 125 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.93276418 |
| 126 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93218213 |
| 127 | MYC_22102868_ChIP-Seq_BL_Human | 0.91485593 |
| 128 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91362019 |
| 129 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.91135120 |
| 130 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.90144360 |
| 131 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.90013916 |
| 132 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.89992399 |
| 133 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.89163088 |
| 134 | GATA1_19941826_ChIP-Seq_K562_Human | 0.88225602 |
| 135 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.88003272 |
| 136 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.87940357 |
| 137 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.87372230 |
| 138 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.87008844 |
| 139 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.86275092 |
| 140 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.86210078 |
| 141 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.85908114 |
| 142 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85884669 |
| 143 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85866984 |
| 144 | TCF4_23295773_ChIP-Seq_U87_Human | 0.85590618 |
| 145 | SPI1_23127762_ChIP-Seq_K562_Human | 0.85322560 |
| 146 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.85028020 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.33183857 |
| 2 | MP0003635_abnormal_synaptic_transmissio | 3.64405853 |
| 3 | MP0000569_abnormal_digit_pigmentation | 3.51198365 |
| 4 | MP0003880_abnormal_central_pattern | 3.37761092 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 3.18465481 |
| 6 | MP0009745_abnormal_behavioral_response | 3.06374469 |
| 7 | MP0002064_seizures | 3.04633819 |
| 8 | MP0009046_muscle_twitch | 2.99112948 |
| 9 | MP0005365_abnormal_bile_salt | 2.93526064 |
| 10 | MP0002063_abnormal_learning/memory/cond | 2.86919029 |
| 11 | MP0001501_abnormal_sleep_pattern | 2.69199407 |
| 12 | MP0003172_abnormal_lysosome_physiology | 2.67611948 |
| 13 | MP0004270_analgesia | 2.60606266 |
| 14 | MP0003690_abnormal_glial_cell | 2.59481799 |
| 15 | MP0005409_darkened_coat_color | 2.47350416 |
| 16 | MP0002572_abnormal_emotion/affect_behav | 2.34610013 |
| 17 | MP0004858_abnormal_nervous_system | 2.30996410 |
| 18 | MP0001968_abnormal_touch/_nociception | 2.26919463 |
| 19 | MP0003303_peritoneal_inflammation | 2.19635414 |
| 20 | MP0005257_abnormal_intraocular_pressure | 2.13269231 |
| 21 | MP0003075_altered_response_to | 2.11382459 |
| 22 | MP0002734_abnormal_mechanical_nocicepti | 2.06411751 |
| 23 | MP0002822_catalepsy | 2.00348029 |
| 24 | MP0003329_amyloid_beta_deposits | 1.99162094 |
| 25 | MP0001486_abnormal_startle_reflex | 1.95044924 |
| 26 | MP0000604_amyloidosis | 1.93751946 |
| 27 | MP0005167_abnormal_blood-brain_barrier | 1.92897242 |
| 28 | MP0002272_abnormal_nervous_system | 1.91515357 |
| 29 | MP0009780_abnormal_chondrocyte_physiolo | 1.90527062 |
| 30 | MP0005058_abnormal_lysosome_morphology | 1.87753366 |
| 31 | MP0004510_myositis | 1.87238126 |
| 32 | MP0003195_calcinosis | 1.84540319 |
| 33 | MP0010329_abnormal_lipoprotein_level | 1.82526956 |
| 34 | MP0005423_abnormal_somatic_nervous | 1.79885120 |
| 35 | MP0002736_abnormal_nociception_after | 1.77665944 |
| 36 | MP0001440_abnormal_grooming_behavior | 1.75140108 |
| 37 | MP0002090_abnormal_vision | 1.74366074 |
| 38 | * MP0002909_abnormal_adrenal_gland | 1.63590740 |
| 39 | MP0003633_abnormal_nervous_system | 1.63406754 |
| 40 | MP0008569_lethality_at_weaning | 1.62433798 |
| 41 | MP0010368_abnormal_lymphatic_system | 1.60648678 |
| 42 | * MP0000639_abnormal_adrenal_gland | 1.58686635 |
| 43 | MP0002733_abnormal_thermal_nociception | 1.55244676 |
| 44 | MP0002067_abnormal_sensory_capabilities | 1.54860993 |
| 45 | MP0001970_abnormal_pain_threshold | 1.49258199 |
| 46 | MP0002735_abnormal_chemical_nociception | 1.46563038 |
| 47 | MP0003123_paternal_imprinting | 1.45876240 |
| 48 | MP0003868_abnormal_feces_composition | 1.42343852 |
| 49 | MP0003183_abnormal_peptide_metabolism | 1.39865359 |
| 50 | MP0004811_abnormal_neuron_physiology | 1.38603536 |
| 51 | MP0001502_abnormal_circadian_rhythm | 1.38090421 |
| 52 | MP0005408_hypopigmentation | 1.37896234 |
| 53 | MP0005646_abnormal_pituitary_gland | 1.35244694 |
| 54 | MP0006082_CNS_inflammation | 1.34305293 |
| 55 | MP0005451_abnormal_body_composition | 1.34294133 |
| 56 | MP0004924_abnormal_behavior | 1.31364446 |
| 57 | MP0005386_behavior/neurological_phenoty | 1.31364446 |
| 58 | MP0002557_abnormal_social/conspecific_i | 1.30987923 |
| 59 | MP0003879_abnormal_hair_cell | 1.29905751 |
| 60 | MP0001984_abnormal_olfaction | 1.28720523 |
| 61 | MP0008961_abnormal_basal_metabolism | 1.27551980 |
| 62 | MP0003631_nervous_system_phenotype | 1.27492241 |
| 63 | MP0008260_abnormal_autophagy | 1.25928058 |
| 64 | MP0005166_decreased_susceptibility_to | 1.22457810 |
| 65 | MP0005085_abnormal_gallbladder_physiolo | 1.21222802 |
| 66 | MP0005360_urolithiasis | 1.19889979 |
| 67 | * MP0001915_intracranial_hemorrhage | 1.17918466 |
| 68 | MP0002089_abnormal_postnatal_growth/wei | 1.16608841 |
| 69 | MP0003634_abnormal_glial_cell | 1.16306455 |
| 70 | MP0002184_abnormal_innervation | 1.13368686 |
| 71 | MP0003878_abnormal_ear_physiology | 1.09921559 |
| 72 | MP0005377_hearing/vestibular/ear_phenot | 1.09921559 |
| 73 | MP0002066_abnormal_motor_capabilities/c | 1.06764203 |
| 74 | MP0003045_fibrosis | 1.05947162 |
| 75 | MP0002882_abnormal_neuron_morphology | 1.03919928 |
| 76 | MP0002118_abnormal_lipid_homeostasis | 1.03248687 |
| 77 | MP0003632_abnormal_nervous_system | 1.02796945 |
| 78 | MP0004885_abnormal_endolymph | 1.02592217 |
| 79 | MP0003787_abnormal_imprinting | 1.02227824 |
| 80 | MP0000778_abnormal_nervous_system | 1.01049468 |
| 81 | MP0002332_abnormal_exercise_endurance | 0.99289784 |
| 82 | MP0000920_abnormal_myelination | 0.98813783 |
| 83 | MP0000955_abnormal_spinal_cord | 0.98743839 |
| 84 | MP0000371_diluted_coat_color | 0.98485453 |
| 85 | MP0008874_decreased_physiological_sensi | 0.94732657 |
| 86 | MP0004130_abnormal_muscle_cell | 0.93628606 |
| 87 | MP0001177_atelectasis | 0.92019485 |
| 88 | MP0003252_abnormal_bile_duct | 0.92006670 |
| 89 | MP0001666_abnormal_nutrient_absorption | 0.91768092 |
| 90 | MP0003566_abnormal_cell_adhesion | 0.91197506 |
| 91 | MP0010234_abnormal_vibrissa_follicle | 0.90354086 |
| 92 | MP0010386_abnormal_urinary_bladder | 0.89549618 |
| 93 | MP0002229_neurodegeneration | 0.88488821 |
| 94 | MP0005535_abnormal_body_temperature | 0.87908825 |
| 95 | MP0005551_abnormal_eye_electrophysiolog | 0.87878294 |
| 96 | MP0005076_abnormal_cell_differentiation | 0.87830203 |
| 97 | MP0003091_abnormal_cell_migration | 0.87520565 |
| 98 | MP0003300_gastrointestinal_ulcer | 0.85565516 |
| 99 | MP0002419_abnormal_innate_immunity | 0.85325517 |
| 100 | MP0000609_abnormal_liver_physiology | 0.84429683 |
| 101 | MP0005171_absent_coat_pigmentation | 0.83903257 |
| 102 | MP0002998_abnormal_bone_remodeling | 0.83780428 |
| 103 | MP0005464_abnormal_platelet_physiology | 0.83255332 |
| 104 | MP0009840_abnormal_foam_cell | 0.81169717 |
| 105 | MP0002254_reproductive_system_inflammat | 0.78143289 |
| 106 | MP0005310_abnormal_salivary_gland | 0.75303978 |
| 107 | MP0005164_abnormal_response_to | 0.74261526 |
| 108 | MP0008875_abnormal_xenobiotic_pharmacok | 0.74137484 |
| 109 | MP0004883_abnormal_blood_vessel | 0.72200008 |
| 110 | MP0002152_abnormal_brain_morphology | 0.68994203 |
| 111 | MP0004381_abnormal_hair_follicle | 0.68746649 |
| 112 | MP0005387_immune_system_phenotype | 0.68474652 |
| 113 | MP0001790_abnormal_immune_system | 0.68474652 |
| 114 | MP0003121_genomic_imprinting | 0.67230532 |
| 115 | MP0002075_abnormal_coat/hair_pigmentati | 0.66371067 |
| 116 | MP0001958_emphysema | 0.65833184 |
| 117 | MP0003436_decreased_susceptibility_to | 0.65809909 |
| 118 | MP0002069_abnormal_eating/drinking_beha | 0.65480182 |
| 119 | MP0008872_abnormal_physiological_respon | 0.64371449 |
| 120 | MP0004742_abnormal_vestibular_system | 0.64087103 |
| 121 | MP0003453_abnormal_keratinocyte_physiol | 0.63855309 |
| 122 | MP0001661_extended_life_span | 0.62661666 |
| 123 | MP0000015_abnormal_ear_pigmentation | 0.62033060 |
| 124 | MP0005248_abnormal_Harderian_gland | 0.62024916 |
| 125 | MP0005645_abnormal_hypothalamus_physiol | 0.61860372 |
| 126 | MP0001835_abnormal_antigen_presentation | 0.61630088 |
| 127 | MP0003656_abnormal_erythrocyte_physiolo | 0.61042473 |
| 128 | MP0003191_abnormal_cellular_cholesterol | 0.60192962 |
| 129 | MP0001756_abnormal_urination | 0.60166741 |
| 130 | * MP0001905_abnormal_dopamine_level | 0.55583962 |
| 131 | MP0004947_skin_inflammation | 0.54379992 |
| 132 | MP0002877_abnormal_melanocyte_morpholog | 0.54309749 |
| 133 | MP0005000_abnormal_immune_tolerance | 0.53766146 |
| 134 | MP0001299_abnormal_eye_distance/ | 0.53725363 |
| 135 | MP0003283_abnormal_digestive_organ | 0.52981233 |
| 136 | MP0004142_abnormal_muscle_tone | 0.51293692 |
| 137 | MP0003122_maternal_imprinting | 0.50469765 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.52244445 |
| 2 | Focal motor seizures (HP:0011153) | 5.50697332 |
| 3 | Complement deficiency (HP:0004431) | 4.85506012 |
| 4 | Glomerulonephritis (HP:0000099) | 4.39563048 |
| 5 | Focal seizures (HP:0007359) | 4.39495383 |
| 6 | Myokymia (HP:0002411) | 4.14679196 |
| 7 | Supranuclear gaze palsy (HP:0000605) | 3.97728853 |
| 8 | Increased cerebral lipofuscin (HP:0011813) | 3.96731879 |
| 9 | Atonic seizures (HP:0010819) | 3.79787003 |
| 10 | Abnormality of complement system (HP:0005339) | 3.75258548 |
| 11 | Action tremor (HP:0002345) | 3.73317311 |
| 12 | Epileptic encephalopathy (HP:0200134) | 3.69012642 |
| 13 | Visual hallucinations (HP:0002367) | 3.67008660 |
| 14 | Febrile seizures (HP:0002373) | 3.65337700 |
| 15 | Systemic lupus erythematosus (HP:0002725) | 3.64498445 |
| 16 | Absence seizures (HP:0002121) | 3.35348353 |
| 17 | Progressive cerebellar ataxia (HP:0002073) | 3.27776240 |
| 18 | Neurofibrillary tangles (HP:0002185) | 3.22917557 |
| 19 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.19626069 |
| 20 | Joint hemorrhage (HP:0005261) | 3.19288653 |
| 21 | Generalized tonic-clonic seizures (HP:0002069) | 3.18707551 |
| 22 | Dialeptic seizures (HP:0011146) | 3.07916171 |
| 23 | Cerebral inclusion bodies (HP:0100314) | 3.03800988 |
| 24 | Mutism (HP:0002300) | 3.01365145 |
| 25 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.00229142 |
| 26 | Abnormality of glycolipid metabolism (HP:0010969) | 3.00229142 |
| 27 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.00229142 |
| 28 | Ankle clonus (HP:0011448) | 2.99556898 |
| 29 | Xanthomatosis (HP:0000991) | 2.98487679 |
| 30 | Prolonged partial thromboplastin time (HP:0003645) | 2.95541091 |
| 31 | Hematochezia (HP:0002573) | 2.85064607 |
| 32 | Mitral stenosis (HP:0001718) | 2.83820202 |
| 33 | Abnormality of binocular vision (HP:0011514) | 2.83191440 |
| 34 | Diplopia (HP:0000651) | 2.83191440 |
| 35 | Recurrent abscess formation (HP:0002722) | 2.79917702 |
| 36 | Postural instability (HP:0002172) | 2.75726496 |
| 37 | Recurrent bacterial skin infections (HP:0005406) | 2.72045420 |
| 38 | Dysdiadochokinesis (HP:0002075) | 2.68153291 |
| 39 | Abnormality of the common coagulation pathway (HP:0010990) | 2.68053972 |
| 40 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.67840535 |
| 41 | Dysmetria (HP:0001310) | 2.67496431 |
| 42 | Alacrima (HP:0000522) | 2.66493086 |
| 43 | Hemiplegia (HP:0002301) | 2.59300335 |
| 44 | Peripheral hypomyelination (HP:0007182) | 2.59252057 |
| 45 | Disinhibition (HP:0000734) | 2.55971568 |
| 46 | Neuronal loss in central nervous system (HP:0002529) | 2.53805938 |
| 47 | Genetic anticipation (HP:0003743) | 2.51394252 |
| 48 | Inappropriate behavior (HP:0000719) | 2.50462854 |
| 49 | Gaze-evoked nystagmus (HP:0000640) | 2.50124210 |
| 50 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.49186080 |
| 51 | Drooling (HP:0002307) | 2.46340265 |
| 52 | Excessive salivation (HP:0003781) | 2.46340265 |
| 53 | Nephritis (HP:0000123) | 2.46254943 |
| 54 | Depression (HP:0000716) | 2.36779778 |
| 55 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.34024942 |
| 56 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.33432966 |
| 57 | Broad-based gait (HP:0002136) | 2.33292504 |
| 58 | Hypercholesterolemia (HP:0003124) | 2.33078993 |
| 59 | Clumsiness (HP:0002312) | 2.31597109 |
| 60 | Apathy (HP:0000741) | 2.30855204 |
| 61 | Purpura (HP:0000979) | 2.30536435 |
| 62 | Loss of speech (HP:0002371) | 2.30071896 |
| 63 | Dysmetric saccades (HP:0000641) | 2.28770927 |
| 64 | Blue irides (HP:0000635) | 2.26994034 |
| 65 | Intention tremor (HP:0002080) | 2.26865003 |
| 66 | Hemorrhage of the eye (HP:0011885) | 2.25019309 |
| 67 | Obstructive sleep apnea (HP:0002870) | 2.24242451 |
| 68 | Hemiparesis (HP:0001269) | 2.23660269 |
| 69 | Hypobetalipoproteinemia (HP:0003563) | 2.23485833 |
| 70 | Abnormal social behavior (HP:0012433) | 2.21119959 |
| 71 | Impaired social interactions (HP:0000735) | 2.21119959 |
| 72 | Abnormality of the lower motor neuron (HP:0002366) | 2.20853714 |
| 73 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.20610801 |
| 74 | Myocardial infarction (HP:0001658) | 2.20506353 |
| 75 | Eczematoid dermatitis (HP:0000976) | 2.20098573 |
| 76 | Absent frontal sinuses (HP:0002688) | 2.20090390 |
| 77 | Abnormal eating behavior (HP:0100738) | 2.19976787 |
| 78 | Dysostosis multiplex (HP:0000943) | 2.19872051 |
| 79 | Truncal ataxia (HP:0002078) | 2.18861671 |
| 80 | Poor eye contact (HP:0000817) | 2.17535140 |
| 81 | Impaired smooth pursuit (HP:0007772) | 2.15034481 |
| 82 | Postural tremor (HP:0002174) | 2.14491434 |
| 83 | Papilledema (HP:0001085) | 2.13269574 |
| 84 | Skin nodule (HP:0200036) | 2.12437704 |
| 85 | Interstitial pulmonary disease (HP:0006530) | 2.10575183 |
| 86 | Decreased lacrimation (HP:0000633) | 2.08510067 |
| 87 | Status epilepticus (HP:0002133) | 2.08133329 |
| 88 | Amyloidosis (HP:0011034) | 2.07089094 |
| 89 | Epidermoid cyst (HP:0200040) | 2.04323580 |
| 90 | Upper motor neuron abnormality (HP:0002127) | 2.03923354 |
| 91 | Diminished motivation (HP:0000745) | 2.02932565 |
| 92 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.01706310 |
| 93 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.01706310 |
| 94 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.01706310 |
| 95 | Gingival bleeding (HP:0000225) | 2.01284990 |
| 96 | Stereotypic behavior (HP:0000733) | 2.00957958 |
| 97 | Lower limb muscle weakness (HP:0007340) | 2.00689114 |
| 98 | Scanning speech (HP:0002168) | 2.00609508 |
| 99 | Bradykinesia (HP:0002067) | 1.99717696 |
| 100 | Arterial tortuosity (HP:0005116) | 1.98883139 |
| 101 | Dementia (HP:0000726) | 1.97765564 |
| 102 | Hyperventilation (HP:0002883) | 1.97027482 |
| 103 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.96277335 |
| 104 | Vertebral compression fractures (HP:0002953) | 1.95827046 |
| 105 | Abnormality of the periventricular white matter (HP:0002518) | 1.93040649 |
| 106 | Mediastinal lymphadenopathy (HP:0100721) | 1.92937740 |
| 107 | Spastic gait (HP:0002064) | 1.92890315 |
| 108 | Cerebral aneurysm (HP:0004944) | 1.91517069 |
| 109 | Progressive inability to walk (HP:0002505) | 1.87956225 |
| 110 | Impaired vibratory sensation (HP:0002495) | 1.87804581 |
| 111 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.87268935 |
| 112 | Aplasia of the phalanges of the hand (HP:0009802) | 1.87268935 |
| 113 | Aplasia involving bones of the extremities (HP:0009825) | 1.87268935 |
| 114 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.86559543 |
| 115 | Mucopolysacchariduria (HP:0008155) | 1.86559543 |
| 116 | Hepatoblastoma (HP:0002884) | 1.86376216 |
| 117 | Abnormality of macrophages (HP:0004311) | 1.86077878 |
| 118 | Retinal atrophy (HP:0001105) | 1.85550318 |
| 119 | Torticollis (HP:0000473) | 1.85148098 |
| 120 | Anxiety (HP:0000739) | 1.82183365 |
| 121 | Bronchomalacia (HP:0002780) | 1.77234261 |
| 122 | Lower limb amyotrophy (HP:0007210) | 1.77000681 |
| 123 | Akinesia (HP:0002304) | 1.76089250 |
| 124 | Abnormality of salivation (HP:0100755) | 1.75485703 |
| 125 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.73812841 |
| 126 | Clonus (HP:0002169) | 1.73003700 |
| 127 | Rapidly progressive (HP:0003678) | 1.72695799 |
| 128 | Supernumerary nipples (HP:0002558) | 1.71848281 |
| 129 | Axonal loss (HP:0003447) | 1.71575626 |
| 130 | Menorrhagia (HP:0000132) | 1.71379485 |
| 131 | Absent speech (HP:0001344) | 1.71208739 |
| 132 | Colitis (HP:0002583) | 1.70967473 |
| 133 | Epileptiform EEG discharges (HP:0011182) | 1.70484660 |
| 134 | Annular pancreas (HP:0001734) | 1.69816194 |
| 135 | Abnormality of saccadic eye movements (HP:0000570) | 1.69466755 |
| 136 | Striae distensae (HP:0001065) | 1.68903723 |
| 137 | Generalized myoclonic seizures (HP:0002123) | 1.68416148 |
| 138 | Global brain atrophy (HP:0002283) | 1.65926637 |
| 139 | Onion bulb formation (HP:0003383) | 1.63906098 |
| 140 | Rigidity (HP:0002063) | 1.61864016 |
| 141 | Slow saccadic eye movements (HP:0000514) | 1.61803597 |
| 142 | Broad face (HP:0000283) | 1.56925191 |
| 143 | Nuclear cataract (HP:0100018) | 1.56813578 |
| 144 | Flat acetabular roof (HP:0003180) | 1.56281423 |
| 145 | Hypolipoproteinemia (HP:0010981) | 1.55996549 |
| 146 | Macroorchidism (HP:0000053) | 1.55577999 |
| 147 | Personality changes (HP:0000751) | 1.55120349 |
| 148 | Ocular albinism (HP:0001107) | 1.54853275 |
| 149 | Asymmetry of the thorax (HP:0001555) | 1.54618031 |
| 150 | Testicular neoplasm (HP:0010788) | 1.53676218 |
| 151 | Abnormality of carpal bone ossification (HP:0006257) | 1.53656530 |
| 152 | Vacuolated lymphocytes (HP:0001922) | 1.52247324 |
| 153 | Hypoglycemic seizures (HP:0002173) | 1.51634602 |
| 154 | Vascular calcification (HP:0004934) | 1.50295631 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 3.87426303 |
| 2 | MAP3K9 | 3.66226661 |
| 3 | NTRK3 | 3.41869143 |
| 4 | RIPK4 | 3.07121616 |
| 5 | DAPK2 | 2.68819207 |
| 6 | FGFR4 | 2.66185775 |
| 7 | MAP3K4 | 2.49548550 |
| 8 | ICK | 2.44662208 |
| 9 | ERN1 | 2.36400935 |
| 10 | MAP3K13 | 2.14360667 |
| 11 | KSR2 | 2.06799659 |
| 12 | PAK6 | 2.01626615 |
| 13 | NTRK1 | 1.99761764 |
| 14 | CAMKK1 | 1.84094046 |
| 15 | PDGFRA | 1.77765575 |
| 16 | NTRK2 | 1.75812806 |
| 17 | CDK12 | 1.66755432 |
| 18 | FES | 1.64531599 |
| 19 | JAK1 | 1.62420111 |
| 20 | MINK1 | 1.61089089 |
| 21 | TYK2 | 1.55074550 |
| 22 | MAP3K2 | 1.53524385 |
| 23 | MAP2K7 | 1.52295825 |
| 24 | AKT3 | 1.48613829 |
| 25 | BMPR2 | 1.43723024 |
| 26 | MAP2K4 | 1.37861882 |
| 27 | FGFR2 | 1.35062866 |
| 28 | MARK1 | 1.34987676 |
| 29 | KSR1 | 1.34721154 |
| 30 | SIK1 | 1.30879154 |
| 31 | CDC42BPA | 1.28499667 |
| 32 | TYRO3 | 1.28106517 |
| 33 | UHMK1 | 1.27441333 |
| 34 | PLK2 | 1.27204643 |
| 35 | PRKD3 | 1.25630874 |
| 36 | CAMKK2 | 1.23443342 |
| 37 | BLK | 1.20368679 |
| 38 | SIK2 | 1.20165576 |
| 39 | EEF2K | 1.19091813 |
| 40 | SGK2 | 1.19037488 |
| 41 | SGK3 | 1.18086714 |
| 42 | CDK5 | 1.17070248 |
| 43 | FGR | 1.15257575 |
| 44 | RIPK1 | 1.14035913 |
| 45 | MAP3K12 | 1.13984583 |
| 46 | DAPK1 | 1.13875267 |
| 47 | PRPF4B | 1.11280520 |
| 48 | PRKCH | 1.09654528 |
| 49 | STK38 | 1.08805984 |
| 50 | TAOK1 | 1.07813670 |
| 51 | ALK | 1.03013683 |
| 52 | GRK5 | 1.00283145 |
| 53 | RET | 1.00109253 |
| 54 | SGK494 | 1.00103413 |
| 55 | SGK223 | 1.00103413 |
| 56 | CASK | 0.97004575 |
| 57 | CAMK1G | 0.94021791 |
| 58 | SCYL2 | 0.93442274 |
| 59 | MAP3K1 | 0.90526968 |
| 60 | NEK6 | 0.83534872 |
| 61 | IRAK3 | 0.81834625 |
| 62 | PDPK1 | 0.81552429 |
| 63 | SMG1 | 0.81159182 |
| 64 | MOS | 0.78004309 |
| 65 | SGK1 | 0.76505952 |
| 66 | LMTK2 | 0.76331947 |
| 67 | MAPK11 | 0.76290647 |
| 68 | PDK1 | 0.74801174 |
| 69 | BMX | 0.73515767 |
| 70 | PRKCG | 0.72266889 |
| 71 | CAMK1 | 0.71598108 |
| 72 | CAMK1D | 0.70847343 |
| 73 | MAP3K14 | 0.70416491 |
| 74 | BRD4 | 0.70206220 |
| 75 | SIK3 | 0.67803470 |
| 76 | TAOK3 | 0.67536284 |
| 77 | WNK1 | 0.67026868 |
| 78 | PTK2B | 0.65581740 |
| 79 | MAPK7 | 0.63959787 |
| 80 | CAMK2A | 0.61369051 |
| 81 | CSF1R | 0.61191636 |
| 82 | TRIB3 | 0.60309745 |
| 83 | PKN2 | 0.57265316 |
| 84 | FER | 0.56881703 |
| 85 | FYN | 0.56062194 |
| 86 | CSK | 0.55941451 |
| 87 | PDGFRB | 0.55754657 |
| 88 | TBK1 | 0.55486386 |
| 89 | CDK19 | 0.54981942 |
| 90 | MATK | 0.54268438 |
| 91 | MAP3K7 | 0.54144017 |
| 92 | ARAF | 0.53908236 |
| 93 | JAK2 | 0.52047948 |
| 94 | STK11 | 0.51368439 |
| 95 | MAP4K1 | 0.51148731 |
| 96 | PHKG1 | 0.51147643 |
| 97 | PHKG2 | 0.51147643 |
| 98 | FGFR3 | 0.50196556 |
| 99 | MTOR | 0.49329802 |
| 100 | PRKAA2 | 0.49206739 |
| 101 | TNK2 | 0.47413535 |
| 102 | EPHB1 | 0.47301345 |
| 103 | NEK9 | 0.46821945 |
| 104 | RPS6KB1 | 0.46659386 |
| 105 | PRKCZ | 0.46613761 |
| 106 | ZAP70 | 0.46375749 |
| 107 | MAPK10 | 0.45932955 |
| 108 | RPS6KA3 | 0.45765548 |
| 109 | PRKD2 | 0.45572122 |
| 110 | CDK6 | 0.45128674 |
| 111 | RPS6KA2 | 0.44783652 |
| 112 | LATS2 | 0.43648786 |
| 113 | MAP3K6 | 0.43442660 |
| 114 | HCK | 0.42938570 |
| 115 | KIT | 0.42751971 |
| 116 | CAMK4 | 0.40877100 |
| 117 | PRKCE | 0.40078703 |
| 118 | HIPK2 | 0.39551748 |
| 119 | SRC | 0.39451710 |
| 120 | MAPK13 | 0.38423076 |
| 121 | CDK15 | 0.38121984 |
| 122 | DYRK1A | 0.37892005 |
| 123 | TGFBR2 | 0.36988893 |
| 124 | ERBB4 | 0.36949678 |
| 125 | TNIK | 0.36896926 |
| 126 | CAMK2B | 0.36841170 |
| 127 | IRAK2 | 0.36645808 |
| 128 | MAPK12 | 0.36561702 |
| 129 | DDR2 | 0.36443900 |
| 130 | MARK2 | 0.35977080 |
| 131 | EGFR | 0.34943603 |
| 132 | JAK3 | 0.34916546 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.98653488 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.83070107 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 2.67150946 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.53487204 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.07941109 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.01511193 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.95266268 |
| 8 | Long-term potentiation_Homo sapiens_hsa04720 | 1.92839379 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.91063050 |
| 10 | Circadian entrainment_Homo sapiens_hsa04713 | 1.90325491 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 1.87081770 |
| 12 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.86437440 |
| 13 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.66046152 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 1.65629392 |
| 15 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.57620377 |
| 16 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.56501571 |
| 17 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.52288795 |
| 18 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.50080187 |
| 19 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.49314903 |
| 20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.48589001 |
| 21 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.48076971 |
| 22 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.43560977 |
| 23 | Insulin secretion_Homo sapiens_hsa04911 | 1.42782573 |
| 24 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.41815737 |
| 25 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.33484610 |
| 26 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.24892388 |
| 27 | Long-term depression_Homo sapiens_hsa04730 | 1.24201458 |
| 28 | Renin secretion_Homo sapiens_hsa04924 | 1.23356385 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.22877419 |
| 30 | Lysosome_Homo sapiens_hsa04142 | 1.20664182 |
| 31 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.20425000 |
| 32 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.20299077 |
| 33 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.17860535 |
| 34 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.16598482 |
| 35 | Cocaine addiction_Homo sapiens_hsa05030 | 1.15222475 |
| 36 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.12860571 |
| 37 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.07649791 |
| 38 | ABC transporters_Homo sapiens_hsa02010 | 1.06962250 |
| 39 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.04546807 |
| 40 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.04497221 |
| 41 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.04283347 |
| 42 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.03465981 |
| 43 | Taste transduction_Homo sapiens_hsa04742 | 1.02227630 |
| 44 | Glioma_Homo sapiens_hsa05214 | 1.01689337 |
| 45 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.00996787 |
| 46 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.00573931 |
| 47 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.99757367 |
| 48 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.99051889 |
| 49 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.98801833 |
| 50 | Tuberculosis_Homo sapiens_hsa05152 | 0.97731697 |
| 51 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.94107560 |
| 52 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.93887440 |
| 53 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.90805738 |
| 54 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.88361439 |
| 55 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.87028173 |
| 56 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.87023197 |
| 57 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.86728437 |
| 58 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.86016980 |
| 59 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.85260902 |
| 60 | Gap junction_Homo sapiens_hsa04540 | 0.85093225 |
| 61 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.84862045 |
| 62 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.84742631 |
| 63 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.84139323 |
| 64 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.81832905 |
| 65 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.81304736 |
| 66 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.81256516 |
| 67 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.80332725 |
| 68 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.80128903 |
| 69 | Phagosome_Homo sapiens_hsa04145 | 0.79191227 |
| 70 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.78375739 |
| 71 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.77823134 |
| 72 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.77666403 |
| 73 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.77082757 |
| 74 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.75952501 |
| 75 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.75400522 |
| 76 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.74302023 |
| 77 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.74052656 |
| 78 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.71895788 |
| 79 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.71375721 |
| 80 | Leishmaniasis_Homo sapiens_hsa05140 | 0.70618052 |
| 81 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.70036268 |
| 82 | Prion diseases_Homo sapiens_hsa05020 | 0.67588131 |
| 83 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.67270554 |
| 84 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.66051605 |
| 85 | Bile secretion_Homo sapiens_hsa04976 | 0.66042766 |
| 86 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.65276011 |
| 87 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.65180575 |
| 88 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.64977791 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64718593 |
| 90 | Salmonella infection_Homo sapiens_hsa05132 | 0.64139436 |
| 91 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.64087197 |
| 92 | Mineral absorption_Homo sapiens_hsa04978 | 0.64053489 |
| 93 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.63643587 |
| 94 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.62810374 |
| 95 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.62113508 |
| 96 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.61676517 |
| 97 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.61229340 |
| 98 | Endometrial cancer_Homo sapiens_hsa05213 | 0.60140630 |
| 99 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58782147 |
| 100 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.58461674 |
| 101 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.58199866 |
| 102 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.57978353 |
| 103 | Axon guidance_Homo sapiens_hsa04360 | 0.57189024 |
| 104 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.57095549 |
| 105 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.56957086 |
| 106 | Insulin resistance_Homo sapiens_hsa04931 | 0.56838011 |
| 107 | Pertussis_Homo sapiens_hsa05133 | 0.56538930 |
| 108 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.56411721 |
| 109 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.56338444 |
| 110 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.56206763 |
| 111 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.55791395 |
| 112 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.55677138 |
| 113 | Lysine degradation_Homo sapiens_hsa00310 | 0.55338917 |
| 114 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.53148288 |
| 115 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.53127402 |
| 116 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.53042160 |
| 117 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.52551773 |
| 118 | Endocytosis_Homo sapiens_hsa04144 | 0.52181289 |
| 119 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.51406858 |
| 120 | Melanogenesis_Homo sapiens_hsa04916 | 0.51401116 |
| 121 | Circadian rhythm_Homo sapiens_hsa04710 | 0.51136759 |
| 122 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.48620305 |
| 123 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.48253704 |
| 124 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.48064649 |
| 125 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.47984571 |
| 126 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.47603744 |
| 127 | Amoebiasis_Homo sapiens_hsa05146 | 0.45255473 |
| 128 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.44974868 |
| 129 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44709721 |
| 130 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.44333899 |

